Mifentidine

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2F70KF5S0K. European Medicines Agency schedules Mifentidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08955MIG. Mifentidine generally arises in the molecular formula C13H16N4. The term MIFENTIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, no. 6, 1984, list 24.) MIFENTIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mifentidine under HS 29332990 and SITC 51573. As of Q4 2014, MIFENTIDINE remains the US FDA Preferred Term for this commodity. Mifentidine bears US NLM identifiers UMLS ID C0128486 and NCI Concept Code C66149. SMILES: N(C1CCC(C2[NH]CNC2)CC1)/C=N/C(C)C.